Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TerraRecon is a global leader in advanced visualization and artificial intelligence solutions for medical imaging. The company provides clinicians with sophisticated tools for 3D post-processing, diagnostic interpretation, and data management across multiple modalities, including CT, MRI, and PET. Its flagship iNtuition platform is widely used in radiology, cardiology, and vascular surgery to improve diagnostic accuracy and surgical planning. Through its EnvoyAI marketplace, TerraRecon facilitates the seamless integration of third-party AI algorithms into clinical workflows. Founded in 1997, the company was acquired by SymphonyAI in 2020 and continues to innovate in the field of medical data reconstruction and analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Terra Recon.